Skip to main content
Top
Published in: Cardiovascular Intervention and Therapeutics 2/2023

07-01-2023 | Lasers in Dermatology | Original Article

Histological evaluation of vascular changes after excimer laser angioplasty for neointimal formation after bare-metal stent implantation in rabbit iliac arteries

Authors: Hirofumi Nagamatsu, Sho Torii, Kazuki Aihara, Keigo Nakazawa, Norihito Nakamura, Satoshi Noda, Satsuki Sekino, Fuminobu Yoshimachi, Gaku Nakazawa, Yuji Ikari

Published in: Cardiovascular Intervention and Therapeutics | Issue 2/2023

Login to get access

Abstract

Background

Excimer laser is used to treat coronary artery disease, especially in case of lesions with thrombus and in-stent restenosis (ISR). However, there are no in vivo preclinical studies that have evaluated the pathological reactions of the vessel wall after excimer laser ablation.

Methods

Bare-metal stents were placed in the external iliac arteries of six healthy rabbits. Twenty-eight days later, excimer laser ablation was performed with low-power (45 (fluency)/25 (rate)) in one side, and high-power (60/40) in the opposite side, followed by optical coherence tomography (OCT) evaluation. Rabbits were sacrificed 15 min after the procedure, and histological assessment was performed.

Results

Morphometry analysis of OCT showed similar stent and lumen size between low-power and high-power group. Histological evaluation suggested endothelial cell loss, fibrin deposition, and tissue loss. The low-power group showed significantly less pathological changes compared with the high-power group: angle of endothelial cell loss, 32.4° vs. 191.7° (interquartile range, 8.8°–131.7° vs. 125.7°–279.5°; p < 0.01); fibrin deposition, 1.1° vs. 59.6° (0.0°–70.4° vs. 31.4°–178.4°; p = 0.03); and tissue loss 0.0° vs. 18.2° (0.0°–8.7° vs. 0.0°–42.7°; p = 0.03).

Conclusions

The pathological changes in neointima were more prominent after high-power excimer laser ablation than after low-power excimer laser. To improve safety in clinical practice, understanding the pathological changes of tissues after excimer laser in lesions with ISR is essential.
Literature
1.
go back to reference Cook SL, Eigler NL, Shefer A, Goldenberg T, Forrester JS, Litvack F. Percutaneous excimer laser coronary angioplasty of lesions not ideal for balloon angioplasty. Circulation. 1991;84:632–43.CrossRefPubMed Cook SL, Eigler NL, Shefer A, Goldenberg T, Forrester JS, Litvack F. Percutaneous excimer laser coronary angioplasty of lesions not ideal for balloon angioplasty. Circulation. 1991;84:632–43.CrossRefPubMed
2.
go back to reference Rawlins J, Din JN, Talwar S, O’Kane P. Coronary intervention with the excimer laser: review of the technology and outcome data. Interv Cardiol. 2016;11:27–32.CrossRefPubMedPubMedCentral Rawlins J, Din JN, Talwar S, O’Kane P. Coronary intervention with the excimer laser: review of the technology and outcome data. Interv Cardiol. 2016;11:27–32.CrossRefPubMedPubMedCentral
3.
go back to reference Tsutsui RS, Sammour Y, Kalra A, et al. Excimer laser atherectomy in percutaneous coronary intervention: a contemporary review. Cardiovasc Revasc Med. 2021;25:75–85.CrossRefPubMed Tsutsui RS, Sammour Y, Kalra A, et al. Excimer laser atherectomy in percutaneous coronary intervention: a contemporary review. Cardiovasc Revasc Med. 2021;25:75–85.CrossRefPubMed
4.
go back to reference Dahm JB, Topaz O, Woenckhaus C, et al. Laser-facilitated thrombectomy: a new therapeutic option for treatment of thrombus-laden coronary lesions. Catheter Cardiovasc Interv. 2002;56:365–72.CrossRefPubMed Dahm JB, Topaz O, Woenckhaus C, et al. Laser-facilitated thrombectomy: a new therapeutic option for treatment of thrombus-laden coronary lesions. Catheter Cardiovasc Interv. 2002;56:365–72.CrossRefPubMed
5.
go back to reference Topaz O, Bernardo NL, Shah R, et al. Effectiveness of excimer laser coronary angioplasty in acute myocardial infarction or in unstable angina pectoris. Am J Cardiol. 2001;87:849–55.CrossRefPubMed Topaz O, Bernardo NL, Shah R, et al. Effectiveness of excimer laser coronary angioplasty in acute myocardial infarction or in unstable angina pectoris. Am J Cardiol. 2001;87:849–55.CrossRefPubMed
7.
go back to reference Sintek M, Coverstone E, Bach R, et al. Excimer laser coronary angioplasty in coronary lesions: use and safety from the NCDR/CATH PCI registry. Circ Cardiovasc Interv. 2021;14:e010061.CrossRefPubMed Sintek M, Coverstone E, Bach R, et al. Excimer laser coronary angioplasty in coronary lesions: use and safety from the NCDR/CATH PCI registry. Circ Cardiovasc Interv. 2021;14:e010061.CrossRefPubMed
8.
go back to reference Nakazawa G, Torii S, Ijichi T et al. Comparison of vascular responses following new-generation biodegradable and durable polymer-based drug-eluting stent implantation in an atherosclerotic rabbit iliac artery model. J Ame Heart Assoc 2016;5. Nakazawa G, Torii S, Ijichi T et al. Comparison of vascular responses following new-generation biodegradable and durable polymer-based drug-eluting stent implantation in an atherosclerotic rabbit iliac artery model. J Ame Heart Assoc 2016;5.
9.
go back to reference Fujihara M, Kurata N, Yazu Y, et al. Clinical expert consensus document on standards for lower extremity artery disease of imaging modality from the Japan Endovascular Treatment Conference. Cardiovasc Interv Ther. 2022;37:597–612.CrossRefPubMed Fujihara M, Kurata N, Yazu Y, et al. Clinical expert consensus document on standards for lower extremity artery disease of imaging modality from the Japan Endovascular Treatment Conference. Cardiovasc Interv Ther. 2022;37:597–612.CrossRefPubMed
10.
go back to reference Fujii K, Kubo T, Otake H, et al. Expert consensus statement for quantitative measurement and morphological assessment of optical coherence tomography: update 2022. Cardiovasc Interv Ther. 2022;37:248–54.CrossRefPubMed Fujii K, Kubo T, Otake H, et al. Expert consensus statement for quantitative measurement and morphological assessment of optical coherence tomography: update 2022. Cardiovasc Interv Ther. 2022;37:248–54.CrossRefPubMed
11.
go back to reference Torii S, Nakazawa G, Ijichi T, Yoshikawa A, Ohno Y, Ikari Y. Comparison of the endothelial coverage in everolimus and zotarolimus-eluting stents in normal, atherosclerotic, and bifurcation rabbit iliac arteries. Cardiovasc Interv Ther. 2018;33:55–61.CrossRefPubMed Torii S, Nakazawa G, Ijichi T, Yoshikawa A, Ohno Y, Ikari Y. Comparison of the endothelial coverage in everolimus and zotarolimus-eluting stents in normal, atherosclerotic, and bifurcation rabbit iliac arteries. Cardiovasc Interv Ther. 2018;33:55–61.CrossRefPubMed
12.
go back to reference Torii S, Yahagi K, Mori H, et al. Biologic drug effect and particulate embolization of drug-eluting stents versus drug-coated balloons in healthy swine femoropopliteal arteries. J Vasc Interv Radiol. 2018;29:1041-1049.e3.CrossRefPubMed Torii S, Yahagi K, Mori H, et al. Biologic drug effect and particulate embolization of drug-eluting stents versus drug-coated balloons in healthy swine femoropopliteal arteries. J Vasc Interv Radiol. 2018;29:1041-1049.e3.CrossRefPubMed
13.
go back to reference Torii S, Yahagi K, Mori H, et al. Safety of zilver PTX drug-eluting stent implantation following drug-coated balloon dilation in a healthy swine model. J Endovasc Ther. 2018;25:118–26.CrossRefPubMed Torii S, Yahagi K, Mori H, et al. Safety of zilver PTX drug-eluting stent implantation following drug-coated balloon dilation in a healthy swine model. J Endovasc Ther. 2018;25:118–26.CrossRefPubMed
14.
go back to reference Torii S, Jinnouchi H, Sakamoto A, et al. Drug-eluting coronary stents: insights from preclinical and pathology studies. Nat Rev Cardiol. 2020;17:37–51.CrossRefPubMed Torii S, Jinnouchi H, Sakamoto A, et al. Drug-eluting coronary stents: insights from preclinical and pathology studies. Nat Rev Cardiol. 2020;17:37–51.CrossRefPubMed
15.
go back to reference Giacoppo D, Alfonso F, Xu B, et al. Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis. J Am Coll Cardiol. 2020;75:2664–78.CrossRefPubMed Giacoppo D, Alfonso F, Xu B, et al. Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis. J Am Coll Cardiol. 2020;75:2664–78.CrossRefPubMed
16.
go back to reference Topaz O, Ebersole D, Das T, et al. Excimer laser angioplasty in acute myocardial infarction (the CARMEL multicenter trial). Am J Cardiol. 2004;93:694–701.CrossRefPubMed Topaz O, Ebersole D, Das T, et al. Excimer laser angioplasty in acute myocardial infarction (the CARMEL multicenter trial). Am J Cardiol. 2004;93:694–701.CrossRefPubMed
17.
go back to reference Nishino M, Mori N, Takiuchi S, et al. Indications and outcomes of excimer laser coronary atherectomy: efficacy and safety for thrombotic lesions—the ULTRAMAN registry. J Cardiol. 2017;69:314–9.CrossRefPubMed Nishino M, Mori N, Takiuchi S, et al. Indications and outcomes of excimer laser coronary atherectomy: efficacy and safety for thrombotic lesions—the ULTRAMAN registry. J Cardiol. 2017;69:314–9.CrossRefPubMed
Metadata
Title
Histological evaluation of vascular changes after excimer laser angioplasty for neointimal formation after bare-metal stent implantation in rabbit iliac arteries
Authors
Hirofumi Nagamatsu
Sho Torii
Kazuki Aihara
Keigo Nakazawa
Norihito Nakamura
Satoshi Noda
Satsuki Sekino
Fuminobu Yoshimachi
Gaku Nakazawa
Yuji Ikari
Publication date
07-01-2023
Publisher
Springer Nature Singapore
Published in
Cardiovascular Intervention and Therapeutics / Issue 2/2023
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-022-00905-8

Other articles of this Issue 2/2023

Cardiovascular Intervention and Therapeutics 2/2023 Go to the issue